|
?:abstract
|
-
In the last Fifty years, several distinct coronaviruses have emerged which causes a diverse variety of human and veterinary ailments Apparently in 2019 during the month of December in Wuhan, China a new strand of coronavirus which was formerly named as \'2019-novel coronavirus (2019-nCoV)\' and now is addressed as SARS-CoV2 (Severe acute respiratory syndrome coronavirus -2) The disease caused by SARS-CoV2 called Covid-19;it is a new public disaster, transmitted from one human to another through various body fluids predominantly through contaminated droplets Covid-19 is forbearing in most people;it can advance to pneumonia, acute respiratory distress syndrome (ARDS), and multiorgan dysfunction in some (usually the elders and those with comorbidities) COVID-19 was called a pandemic by the World Health Organization (WHO) on March 11, 2020 One concern would be how capable the health care systems of the world are to respond to an epidemic of this magnitude In different regions, rapid identification, and control of the virus at the entry points is crucial throughout in order to prevent widespread population transmission Based on current published evidence, a summary of various curbing measures with prevention and tenacity of SARS-Cov2 is provided in this review article Through this review we also provide information about the clinical trials for vaccines and treatment filed by different pharma companies which is one of the most awaited and dominant research in current scenarios around the globe Copyright © 2020 Annamacharya College of Pharmacy All rights reserved
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}